{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:49:50Z","timestamp":1789753790117,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.jchromb.2015.03.028","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T08:16:30Z","timestamp":1428308190000},"page":"141-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Simultaneous quantification of fosinopril and its active metabolite fosinoprilat in rat plasma by UFLC-MS\/MS: Application of formic acid in the stabilization of an ester-containing drug"],"prefix":"10.1016","volume":"990","author":[{"given":"Kewen","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqin","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2015.03.028_bib0120","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/00005344-198911000-00009","article-title":"Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology","volume":"14","author":"DeForrest","year":"1989","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0378-4347(99)00551-4","article-title":"Liquid chromatographic-electrospray tandem mass spectrometric method for the simultaneous quantitation of the prodrug fosinopril and the active drug fosinoprilat in human serum","volume":"739","author":"Jemal","year":"2000","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jchromb.2007.04.019","article-title":"Development and validation of liquid chromatography-tandem mass spectrometric method for simultaneous determination of fosinopril and its active metabolite fosinoprilat in human plasma","volume":"854","author":"Cui","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jchromb.2006.12.054","volume":"852","author":"Zeng","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0140","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0378-4347(00)00300-5","article-title":"Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine","volume":"745","author":"Wiltshire","year":"2000","journal-title":"J. Chromatogr. B Biomed Sci. Appl."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0145","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jpba.2013.10.014","article-title":"Application of a stabilizer cocktail of N-ethylmaleimide and phenylmethanesulfonyl fluoride to concurrently stabilize the disulfide and ester containing compounds in a plasma LC-MS\/MS assay","volume":"88","author":"Yuan","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0150","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0009-9120(01)00270-3","article-title":"Plasma ascorbic acid: measurement, stability and clinical utility revisited","volume":"34","author":"Chung","year":"2001","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0155","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/bmc.737","article-title":"Stability of caffeic acid phenethyl ester and its fluorinated derivative in rat plasma","volume":"21","author":"Wang","year":"2007","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4155\/bio.09.20","article-title":"Factors affecting the stability of drugs and drug metabolites in biological matrices","volume":"1","author":"Briscoe","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2015.03.028_bib0165","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1021\/ac010532d","article-title":"LC\/MS\/MS determination of omapatrilat, a sulfhydryl-containing vasopeptidase inhibitor, and its sulfhydryl- and thioether-containing metabolites in human plasma","volume":"73","author":"Jemal","year":"2001","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0170","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/bmc.1572","article-title":"Strategies in quantitative LC-MS\/MS analysis of unstable small molecules in biological matrices","volume":"25","author":"Li","year":"2011","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0175","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jpba.2009.09.023","article-title":"Improving the ex vivo stability of drug ester compounds in rat and dog serum: inhibition of the specific esterases and implications on their identity","volume":"51","author":"Koitka","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0180","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/jps.20542","article-title":"Enzymes involved in the bioconversion of ester-based prodrugs","volume":"95","author":"Liederer","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0185","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4155\/bio.10.30","article-title":"Effective screening approach to select esterase inhibitors used for stabilizing ester-containing prodrugs analyzed by LC-MS\/MS","volume":"2","author":"Fung","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2015.03.028_bib0190","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Guidance for Industry, Bioanalytical Method Validation, 2001, http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm070107.pdf (accessed 20.05.13)."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0195","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0006-2952(95)00071-7","article-title":"Species differences in hydrolysis of isocarbacyclin methyl ester (TEI-9090) by blood esterases","volume":"49","author":"Minagawa","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0200","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00007691-200104000-00014","article-title":"In vitro stability of cocaine in whole blood and plasma including ecgonine as a target analyte","volume":"23","author":"Skopp","year":"2001","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0205","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijpharm.2005.06.003","article-title":"Stability of dexamethasone sodium phosphate in rat plasma","volume":"301","author":"Samtani","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0210","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.4155\/bio.10.60","article-title":"Critical topics in ensuring data quality in bioanalytical LC-MS method development","volume":"2","author":"Mulvana","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2015.03.028_bib0215","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jchromb.2014.05.048","article-title":"Development and validation of an LC-MS\/MS method for determination of the L-type voltage-gated calcium channel\/NMDA receptor antagonist NGP 1-01 in mouse serum","volume":"963","author":"Jogiraju","year":"2014","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0220","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/jps.10491","article-title":"Enhanced intestinal absorption of drugs by activation of peptide transporter PEPT1 using proton-releasing polymer","volume":"92","author":"Nozawa","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0225","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1124\/jpet.108.143339","article-title":"Transport of angiotensin-converting enzyme inhibitors by H+\/peptide transporters revisited","volume":"327","author":"Knutter","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jchromb.2015.03.028_bib0230","first-page":"1307","article-title":"Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures","volume":"29","author":"Shu","year":"2001","journal-title":"Drug Metab. Dispos."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002321500197X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002321500197X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T21:20:52Z","timestamp":1537737652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157002321500197X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":23,"alternative-id":["S157002321500197X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2015.03.028","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous quantification of fosinopril and its active metabolite fosinoprilat in rat plasma by UFLC-MS\/MS: Application of formic acid in the stabilization of an ester-containing drug","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2015.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}